We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-8.3%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$141B
AUM Growth
-$9.21B
Cap. Flow
+$6.71B
Cap. Flow %
4.75%
Top 10 Hldgs %
17.26%
Holding
9,177
New
664
Increased
3,305
Reduced
3,724
Closed
707

Sector Composition

Rank Sector Weight
1 Financials 8.11%
2 Healthcare 6.31%
3 Energy 6.06%
4 Technology 5.81%
5 Industrials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAS
7976
DELISTED
A M Castle & Co
CAS
$3K ﹤0.01%
1,405
+843
+150% +$2.95K
GMAN
7977
DELISTED
Gordmans Stores, Inc.
GMAN
$3K ﹤0.01%
906
-3,996
-82% -$18.2K
ABCW
7978
DELISTED
ANCHOR BANCORP WISCONSIN INC COMMON STOCK
ABCW
$3K ﹤0.01%
+61
New +$2.45K
IFO
7979
DELISTED
INFOSONICS CORPORATION
IFO
$3K ﹤0.01%
2,427
-730
-23% -$902
AG icon
7980
PUT
First Majestic Silver
AG
$7.41B
$2K ﹤0.01%
700
ANIP icon
7981
ANI Pharmaceuticals
ANIP
$1.8B
$2K ﹤0.01%
59
-8,590
-99% -$489K
ANY icon
7982
Sphere 3D
ANY
$18.5M
0
ARCT icon
7983
Arcturus Therapeutics
ARCT
$164M
$2K ﹤0.01%
57
-1,073
-95% -$56.4K
ARKQ icon
7984
ARK Autonomous Technology & Robotics ETF
ARKQ
$1.9B
$2K ﹤0.01%
+135
New +$2.54K
AXON
7985
CALL
Axon Enterprise
AXON
$42.5B
$2K ﹤0.01%
100
-500
-83% -$13.2K
BBC icon
7986
Virtus Biotech Clinical Trials ETF
BBC
$46.3M
$2K ﹤0.01%
77
-781
-91% -$26.4K
BCLI
7987
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$2K ﹤0.01%
68
BGI icon
7988
Birks Group
BGI
$9.46M
$2K ﹤0.01%
2,386
+999
+72% +$948
BNO icon
7989
United States Brent Oil Fund
BNO
$781M
$2K ﹤0.01%
135
-815
-86% -$14.6K
BSX icon
7990
CALL
Boston Scientific
BSX
$69.5B
$2K ﹤0.01%
100
-323,200
-100% -$5.52M
BXC icon
7991
BlueLinx
BXC
$422M
$2K ﹤0.01%
+327
New +$2.91K
CARM
7992
DELISTED
Carisma Therapeutics
CARM
$2K ﹤0.01%
50
-26
-34% -$1.6K
CCLD icon
7993
CareCloud
CCLD
$104M
$2K ﹤0.01%
1,110
+61
+6% +$121
CDC icon
7994
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
CDC
$738M
$2K ﹤0.01%
65
CYRX icon
7995
CryoPort
CYRX
$761M
$2K ﹤0.01%
+1,046
New +$2.96K
DALN
7996
DELISTED
DallasNews
DALN
$2K ﹤0.01%
80
DHC
7997
CALL
Diversified Healthcare Trust
DHC
$2.15B
$2K ﹤0.01%
101
DOMH icon
7998
Dominari Holdings
DOMH
$57.4M
$2K ﹤0.01%
5
-12
-71% -$6.07K
DRRX
7999
DELISTED
DURECT Corp
DRRX
$2K ﹤0.01%
95
DUST icon
8000
CALL
Direxion Daily Gold Miners Index Bear 2X ETF
DUST
$70.6M
0

Similar funds

UBS Group's Q3 2015 Portfolio in Review

As of Q3 2015, UBS Group held 9,177 positions worth $141B, down 6.1% from $150B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

UBS Group deployed $6.71B of net new capital in Q3 2015, opening 664 new positions and adding to 3,305 existing holdings. Its largest new stake was Kraft Heinz: 1,448,913 shares worth $102M.

By sector, the portfolio is most concentrated in Financials at 8.1% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was Apple, an estimated $399M trimmed.

  • UBS Group's largest Q3 2015 buy was Kraft Heinz: 1,448,913 shares worth $102M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2015, an estimated $2.97B increase.
  • UBS Group's biggest Q3 2015 reduction was Apple, cutting an estimated $399M.
  • UBS Group fully exited OMNICARE INC in Q3 2015, selling an estimated $227M.
  • UBS Group's ten largest holdings make up 17% of its $141B portfolio in Q3 2015.
  • UBS Group opened 664 new positions and closed 707 in Q3 2015.
  • UBS Group's portfolio value fell 6.1% quarter-over-quarter to $141B.

Based on UBS Group's 13F filing for Q3 2015, filed 13 Nov 2015.